SKBA Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28M | Buy |
323,712
+11,000
| +4% | +$1.05M | 3.85% | 1 |
|
|
2025
Q4 | $30M | Sell |
312,712
-50
| -0% | -$4.86K | 4.26% | 1 |
|
|
2025
Q3 | $29.8M | Buy |
312,762
+11,500
| +4% | +$1.06M | 4.12% | 1 |
|
|
2025
Q2 | $26.3M | Buy |
301,262
+26,950
| +10% | +$2.29M | 3.78% | 2 |
|
|
2025
Q1 | $24.6M | Buy |
274,312
+5,251
| +2% | +$470K | 3.67% | 3 |
|
|
2024
Q4 | $21.5M | Buy |
269,061
+35,400
| +15% | +$3.06M | 3.4% | 4 |
|
|
2024
Q3 | $21M | Buy |
233,661
+13,200
| +6% | +$1.11M | 3.12% | 5 |
|
|
2024
Q2 | $17.4M | Buy |
220,461
+4,417
| +2% | +$362K | 2.78% | 8 |
|
|
2024
Q1 | $18.8M | Buy |
216,044
+40,515
| +23% | +$3.46M | 2.94% | 6 |
|
|
2023
Q4 | $14.5M | Buy |
175,529
+38,395
| +28% | +$2.93M | 2.44% | 13 |
|
|
2023
Q3 | $10.7M | Buy |
137,134
+20,030
| +17% | +$1.68M | 1.98% | 21 |
|
|
2023
Q2 | $10.3M | Buy |
117,104
+29,300
| +33% | +$2.52M | 1.86% | 24 |
|
|
2023
Q1 | $7.08M | Sell |
87,804
-200
| -0.2% | -$16.3K | 1.32% | 42 |
|
|
2022
Q4 | $6.84M | Sell |
88,004
-540
| -0.6% | -$43.8K | 1.26% | 42 |
|
|
2022
Q3 | $7.15M | Buy |
88,544
+1,150
| +1% | +$103K | 1.52% | 35 |
|
|
2022
Q2 | $7.84M | Sell |
87,394
-500
| -0.6% | -$50.7K | 1.57% | 33 |
|
|
2022
Q1 | $9.75M | Sell |
87,894
-1,325
| -1% | -$140K | 1.76% | 30 |
|
|
2021
Q4 | $9.23M | Buy |
89,219
+9,123
| +11% | +$1.06M | 1.74% | 29 |
|
|
2021
Q3 | $10M | Sell |
80,096
-150
| -0.2% | -$19.4K | 2% | 19 |
|
|
2021
Q2 | $9.96M | Sell |
80,246
-17,200
| -18% | -$2.16M | 1.95% | 23 |
|
|
2021
Q1 | $11.5M | Sell |
97,446
-5,200
| -5% | -$609K | 1.83% | 26 |
|
|
2020
Q4 | $12M | Buy |
102,646
+10,800
| +12% | +$1.19M | 2.01% | 20 |
|
|
2020
Q3 | $9.54M | Sell |
91,846
-5,600
| -6% | -$562K | 1.91% | 19 |
|
|
2020
Q2 | $8.94M | Sell |
97,446
-1,000
| -1% | -$95.9K | 1.74% | 26 |
|
|
2020
Q1 | $8.88M | Sell |
98,446
-12,900
| -12% | -$1.37M | 2.02% | 22 |
|
|
2019
Q4 | $12.6M | Sell |
111,346
-9,200
| -8% | -$1.01M | 2% | 20 |
|
|
2019
Q3 | $13.1M | Sell |
120,546
-12,490
| -9% | -$1.3M | 2.08% | 16 |
|
|
2019
Q2 | $13M | Sell |
133,036
-27,400
| -17% | -$2.5M | 2.07% | 14 |
|
|
2019
Q1 | $14.6M | Sell |
160,436
-15,700
| -9% | -$1.41M | 2.35% | 16 |
|
|
2018
Q4 | $16M | Sell |
176,136
-31,400
| -15% | -$2.93M | 2.6% | 11 |
|
|
2018
Q3 | $20.4M | Buy |
207,536
+27,650
| +15% | +$2.56M | 2.65% | 11 |
|
|
2018
Q2 | $15.4M | Sell |
179,886
-2,350
| -1% | -$196K | 2.08% | 16 |
|
|
2018
Q1 | $14.6M | Buy |
182,236
+88,100
| +94% | +$7.27M | 1.98% | 21 |
|
|
2017
Q4 | $7.6M | Buy |
94,136
+90,740
| +2,672% | +$7.27M | 1.06% | 45 |
|
|
2017
Q3 | $264K | Buy |
3,396
+500
| +17% | +$41.5K | 0.04% | 67 |
|
|
2017
Q2 | $257K | Buy |
+2,896
| New | +$244K | 0.04% | 67 |
|
Other funds holding MDT
VCM
VPM
SKBA Capital Management's MDT Position: Q1 2026 in Review
SKBA Capital Management increased its Medtronic (MDT) stake by 3.5% in Q1 2026, buying an estimated $1.05M and bringing the position to 323,712 shares worth $28M. The position accounts for 3.85% of the portfolio, ranked #1.
SKBA Capital Management first reported a position in MDT in Q2 2017 and has held it in 36 quarters since. The position peaked at $30M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- SKBA Capital Management held 323,712 shares of Medtronic worth $28M as of Q1 2026.
- SKBA Capital Management bought 11,000 Medtronic shares in Q1 2026, an estimated $1.05M.
- Medtronic made up 3.85% of SKBA Capital Management's portfolio in Q1 2026, its #1 holding.
- SKBA Capital Management first reported a position in Medtronic in Q2 2017 and has held it in 36 quarters since.
- SKBA Capital Management's Medtronic position peaked at $30M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on SKBA Capital Management's 13F filing for Q1 2026, filed 13 May 2026.